The Technical Analyst
GX Acquisition Corp [GXGX]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
GX Acquisition Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
27.18% $10.20
America/New_York / 19 jul 2021 @ 00:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 479.13 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 145.01 mill |
| Avg Daily Volume: | 0.622 mill |
| RATING 2022-02-09 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.17 - 10.24 ( +/- 0.34%) |
| ATR Model: 14 days |
Forecast:
01:40 - $10.05
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.20 (27.18% ) |
| Volume | 17.32 mill |
| Avg. Vol. | 0.622 mill |
| % of Avg. Vol | 2 785.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For GXGX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
GXGX
GX Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and it has not generated any revenue.
Latest Press Releases
2021-05-14 16:45:00 - Press Release
Gx Acquisition Corp. Announces Shareholder Approval Of Extension Proposal
New york, may 14, 2021 /prnewswire/ -- gx acquisition corp. ("gx") (nasdaq: gxgx), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an amendment to gx's amended and restated certificate of incorporation to extend the date by which gx must effectuate its initial business combination from may 23, 2021 to july 31, 2021. as previously disclosed, on january 8, 2021, gx entered into a merger agreement and plan of reorganization (the "merger agreement") with celularity inc. ("celularity"), alpha first merger sub, inc. and alpha second merger sub, llc.
2021-05-10 07:30:00 - Press Release
Gx Acquisition Corp. Announces Additional Contributions To Trust Account
New york, may 10, 2021 /prnewswire/ -- gx acquisition corp. ("gx") (nasdaq: gxgx), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend gx's amended and restated certificate of incorporation to extend the date by which gx must complete its initial business combination from may 23, 2021 to july 31, 2021 (the "extension" and such later date, the "extended date"). this proposal will be voted on by stockholders at the upcoming special meeting of stockholders on may 14, 2021.
2020-09-16 00:00:00 - Press Release
Global Nutrigenomics Market- Featuring Basf Se, Cell-logic, Danone, Dsm, And Genova Diagnostics Inc. Among Others | technavio
The global nutrigenomics market will grow by usd 425.61 mn during 2020-2024
Latest News
2021-07-16 16:09:19 - The Motley Fool
Why GX Acquisition Stock Soared Today
2021-07-16 14:39:05 - InvestorPlace
GXGX Merger: The SPAC News That Has GXGX Stock Soaring
GXGX's merger announcement is causing the stock to soar this afternoon. The SPAC is merging with biotech play Celularity.
2021-05-14 16:45:00 - PRNewsWire
GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal
NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an amendment to GX's amended and restated certificate of incorporation to extend the date by which GX must effectuate its initial business combination from May 23, 2021 to July 31, 2021. As previously disclosed, on January 8, 2021, GX entered into a Merger Agreement and Plan of Reorganization (the "Merger Agreement") with Celularity Inc. ("Celularity"), Alpha First Merger Sub, Inc. and Alpha Second Merger Sub, LLC.
2021-05-10 07:30:00 - PRNewsWire
GX Acquisition Corp. Announces Additional Contributions to Trust Account
NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX's amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021.
2021-03-03 13:14:44 - InvestorPlace
7 Upcoming SPAC Mergers to Avoid
The stock market has suddenly broken to the downside over the past two weeks. That makes these SPACs particularly risky bets as the momentum fades.
2020-09-16 00:00:00 - businesswire
Global Nutrigenomics Market- Featuring BASF SE, Cell-Logic, Danone, DSM, and Genova Diagnostics Inc. Among Others | Technavio
